VUIK, Fanny E. R., Stella A. V. NIEUWENBURG, Marc BARDOU, Iris LANSDORP-VOGELAAR, Mario DINIS-RIBEIRO, Maria J BENTO, Vesna ZADNIK, Maria PELLISE, Laura ESTEBAN, Michal F. KAMINSKI, Stepan SUCHANEK, Ondřej NGO, Ondřej MÁJEK, Marcis LEJA, Ernst J. KUIPERS a Manon C. W. SPAANDER. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut. LONDON: BMJ PUBLISHING GROUP, roč. 68, č. 10, s. 1820-1826. ISSN 0017-5749. doi:10.1136/gutjnl-2018-317592. 2019.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
Autoři VUIK, Fanny E. R. (528 Nizozemské království), Stella A. V. NIEUWENBURG (528 Nizozemské království), Marc BARDOU (528 Nizozemské království), Iris LANSDORP-VOGELAAR (528 Nizozemské království), Mario DINIS-RIBEIRO (620 Portugalsko), Maria J BENTO (620 Portugalsko), Vesna ZADNIK (705 Slovinsko), Maria PELLISE (724 Španělsko), Laura ESTEBAN (724 Španělsko), Michal F. KAMINSKI (616 Polsko), Stepan SUCHANEK (203 Česká republika), Ondřej NGO (203 Česká republika, domácí), Ondřej MÁJEK (203 Česká republika, domácí), Marcis LEJA (203 Česká republika), Ernst J. KUIPERS (528 Nizozemské království) a Manon C. W. SPAANDER (528 Nizozemské království, garant).
Vydání Gut, LONDON, BMJ PUBLISHING GROUP, 2019, 0017-5749.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30219 Gastroenterology and hepatology
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 19.819
Kód RIV RIV/00216224:14110/19:00111742
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1136/gutjnl-2018-317592
UT WoS 000496491100012
Klíčová slova anglicky RISK-FACTORS; COLON-CANCER; METAANALYSIS
Štítky 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 17. 12. 2019 07:35.
Anotace
Objective The incidence of colorectal cancer (CRC) declines among subjects aged 50 years and above. An opposite trend appears among younger adults. In Europe, data on CRC incidence among younger adults are lacking. We therefore aimed to analyse European trends in CRC incidence and mortality in subjects younger than 50 years. Design Data on age-related CRC incidence and mortality between 1990 and 2016 were retrieved from national and regional cancer registries. Trends were analysed by Joinpoint regression and expressed as annual percent change. Results We retrieved data on 143.7 million people aged 20-49 years from 20 European countries. Of them, 187 918 (0.13%) were diagnosed with CRC. On average, CRC incidence increased with 7.9% per year among subjects aged 20-29 years from 2004 to 2016. The increase in the age group of 30-39 years was 4.9% per year from 2005 to 2016, the increase in the age group of 40-49 years was 1.6% per year from 2004 to 2016. This increase started earliest in subjects aged 20-29 years, and 10-20 years later in those aged 30-39 and 40-49 years. This is consistent with an age-cohort phenomenon. Although in most European countries the CRC incidence had risen, some heterogeneity was found between countries. CRC mortality did not significantly change among the youngest adults, but decreased with 1.1%per year between 1990 and 2016 and 2.4% per year between 1990 and 2009 among those aged 30-39 years and 40-49 years, respectively. Conclusion CRC incidence rises among young adults in Europe. The cause for this trend needs to be elucidated. Clinicians should be aware of this trend. If the trend continues, screening guidelines may need to be reconsidered.
VytisknoutZobrazeno: 17. 4. 2024 00:04